Sylvester Comprehensive Cancer Center Advances Clinical Trial Participation
Sylvester Comprehensive Cancer Center Advances Clinical Trial Participation Oncodaily
Sylvester Comprehensive Cancer Center Advances Clinical Trial Participation Oncodaily
10x Genomics partners with Fred Hutch to advance cancer research using single cell and spatial technologies. Pluang
Ученые перепрограммируют иммунные клетки в организме для борьбы с раком open.kg
Eating more sugar while taking antibiotics was linked to greater disruption of the gut microbiome and increased growth of potentially harmful bacteria. Researchers say temporarily cutting back on sweets during and after antibiotic treatment could be a simple way to reduce this damage, though clinical trials are still…
10x Genomics partners with Fred Hutch on cancer research By Investing.com Investing.com UK
В больнице Страдиня — большой интерес к бесплатному генетическому скринингу риска рака груди и яичников LSM
Кето-диета влияет на злокачественные опухоли: что показали исследования socportal.info
A pancreatic cancer trial will test chemo near the tumor before surgery. Its first patient has enrolled. Stock Titan
MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer Yahoo Finance Australia
150 people have received an experimental lung cancer drug in trials involving immunotherapy Stock Titan
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s…
MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ Fierce Biotech
MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma Roswell Park Comprehensive Cancer Center
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma Business Wire